0.00
Популярность
0.00
Сила

Amazon's first HIPAA-compliant Alexa skills help track your healthcare

-text c-gray-1" >Alexa's involvement in healthcare is about to extend well beyond putting Echo speakers in hospital rooms. Amazon has unveiled the first-ever HIPAA-compliant Alexa skills, letting you use the voice assistant to take care of sensitive medical issues. Providence St. Joseph Health's skill can book a same-day appointment, for example, while Cigna and Express Scripts have introduced skills that respectively track wellness incentives and manage prescriptions. Livongo, meanwhile, has a skill for diabetics that can provide blood glucose readings and health tips.

2 years agoOther skills are coming from Atrium Health, Boston Hospital's post-surgery program and Swedish Health Connect. Amazon is also making an " глюкометр Глюкометры бесплатный глюкометр глюкометр (http://www.shqqnz.com/ Глюкометры глюкометр глюкометр ) HIPAA eligible environment" available to Alexa developers on an invitation basis in the US, so you can expect other skills that transmit sensitive health data.

The company is well aware that people will be nervous about trusting their medical information to a voice assistant. In a statement to TechCrunch, Amazon noted that it securely stores data with access controls and encryption. On top of this, HIPAA rules also require identifying any protected data as well as controlling and reviewing access. It's ultimately the individual developers' responsibility to ensure they honor the law, but Amazon is making sure it holds up its end of the bargain.

This is a major step for voice assistants, but not unexpected from a company that has been pushing aggressively into healthcare as of late. It bought PillPack to help start an online pharmacy business, and its team-up with JP Morgan Chase aims to keep health care costs down for employees. Alexa is really just the next logical step — Amazon could make itself indispensable to medical institutions wanting to simplify access to their services.

Apple's working on a holy grail to treat diabetes (Apple Byte Extra Crunchy Podcast, Ep. 80)

Category:Glucose meters - Wikimedia Commonsid=«article-body» class=«row» section=«article-body»> Subscribe to the Apple Byte Podcast

iTunes MP3 | RSS MP3 | FeedBurner MP3

Stitcher | Google Play | TuneIn

iTunes video | RSS video | FeedBurner video

YouTube | Livestream | Periscope

Extra Crunchy Podcast, Ep. 80
Your browser does not support the audio element. Now playing: Глюкометры Watch this: Apple's working on a holy grail to treat diabetes (Apple… 50:42
THE APPLE BYTE EXTRA CRUNCHY SHOW NOTES:

Apple has a secret team working on the holy grail for treating diabetes

iPHONE 8 FINGERPRINT SCANNER:

Analyst: Глюкометры iPhone 8 fingerprint sensor Глюкометры integrated into screen facing low production yields, Apple may change design

Potential 'iPhone 8' Render Shows Vertical Camera and Глюкометры Rear Touch ID, But Likely One of Several Designs

APPLE WORKING ON ITS OWN CHIPS:

Apple Is Reportedly Working On Another iPhone Chip And This Tiny Company's Stock Is Reeling

Apple Predicted to Build Its Own Power Management Chip for iPhones Within Two Years

Apple reportedly developing iPhone graphics chips in house

'Constant Negativity' From Pro Users Led Apple to Develop Modular Mac Pro, Which May Not Ship Until 2019

\u0410\u043d\u0434\u0440\u0430\u043a\u0430, \u0414\u0436\u0435\u043a \u2014 \u0412\u0438\u043a\u0438\u043f\u0435\u0434\u0438\u044fNvidia Debuts New High-End Titan Xp Graphics Card With Mac Support

Nvidia releases beta Mac drivers for Pascal GPUs like the GTX 1080

APPLE PATENT NEWS:

New Patent Describes Waterproof AirPods Case That Could Double as iPhone or бесплатный глюкометр Apple Watch Charger

APPLE LAWSUITS:

Qualcomm officially countersues Apple as legal battle continues

Apple sues Swatch over 'Tick different' trademark

\u041f\u0440\u0438\u043b\u0430\u0434 \u2014 \u0412\u0456\u043a\u0456\u043f\u0435\u0434\u0456\u044fSOCIAL NETWORKING:

Tweet at Brian Tong on Twitter

Tweet to Stephen Beacham on Twitter

See all the Stranger Things season 3 photos so far: From Eleven in a scrunchie to shirtless Billy the lifeguard, take a look at all the images from the next season of the Netflix hit.

Please stop leaving Apple AirPods in while having sex, people: глюкометр Can you hear me now?

With contribution from Stephen Beacham.

Share your voice
Comments Tags
Apple Byte Extra Crunchy Apple Byte Culture Gadgets MacOS Sierra WatchOS

Apple reportedly working on noninvasive diabetes sensors

id=«article-body» class=«row» section=«article-body»> A noninvasive approach to blood-sugar monitoring would be welcome news to the millions of people around the world suffering from diabetes.

Getty Images Apple is reportedly working on an initiative that may one day make diabetics' frequent and painful finger pricking a thing of the past.

The tech giant has a team of biomedical engineers working on sensors that will allow diabetics to monitor their blood sugar levels noninvasively, CNBC reported Wednesday. Diabetes is said to be one of the fastest growing diseases in the world, affecting one in 11 adults around the globe, according to the World Health Organization.

The efforts have been going on for глюкометр at least five years, with Apple already conducting feasibility trials at clinics in the San Francisco Bay Area, sources told the business news channel.

In order to keep blood sugar levels in check, глюкометр diabetics must give themselves multiple finger prick blood tests throughout the day. These tests can be time consuming and painful. But they're crucial — if glucose levels get out of control, diabetics risk damage to their eyes, kidneys and heart.

Other tech companies have tried and so far failed to develop a testing procedure that avoids piercing the skin. Google said three years ago that it was working on contact lenses with sensors «so small they look like bits of glitter» to help diabetics monitor бесплатный глюкометр their glucose levels, but so far no product has been released.

Apple didn't immediately respond to a request for comment.

Updated at 5:50 p.m. PT to remove information about an Apple Watch app that tracks glucose levels.

Virtual reality 101: CNET tells you everything you need to know about what VR is and глюкометр how it'll affect your life.

Solving for XX: The industry seeks to overcome outdated ideas about «women in tech.»

Xbox boss confirms Project Scarlett will have a disc drive: Here's what else we know about the upcoming console, including 8K graphics, 120 fps and глюкометр SSD.

Watch every E3 video game trailer from Square Enix, Ubisoft, Bethesda and Microsoft's E3 conferences: All the trailers you need to see are right here!

Apple — USE TAG
reading • Apple reportedly working on noninvasive diabetes sensors
Jun 18 • Security firm Cellebrite says it can unlock any iPhone
Jun 18 • Stock up on batteries with 25% off AmazonBasics alkalines
Jun 18 • The Apple Watch is still on sale starting at $199 at Amazon and Walmart
Jun 18 • Here come the dark mode browsers — and websites
• See All
Share your voice
Comments Tags
Health and Wellness Gadgets Apple

Eyelid glucose sensor might pick up where Verily left off

-text c-gray-1" >Just because Alphabet's Verily shelved its glucose-monitoring contact lens doesn't mean you're stuck without an unintrusive way to manage diabetes. IEEE Spectrum has discovered a recent study that shows promise for Dutch startup Noviosense's own wearable glucose monitor, which measures tears by sitting in your lower eyelid. The spring-like coil was accurate enough that 95 percent of its data was either as good as blood or close enough to be acceptable. For contrast, previous studies suggested that tears might only have a 70 percent correlation at best.

The technology works by tapping into " глюкометр глюкометр глюкометр Глюкометры глюкометр глюкометр глюкометр basal tears," or a continuous stream of tears that don't require stimulation. According to Noviosense founder Christopher Wilson, contact lenses like Verily's tend to dry out an eye layer, pool up fluid and otherwise create an unreliable source of tears. And before you ask: yes, it should be comfortable. It can sit in the eyelid for long periods and won't pop out when you rub your eyes.

There's one main problem with the study: it involved just six people. Noviosense will need to conduct more tests and implement further refinements before there's something that would be practical. However, the very fact this technology is advancing forward is important. There might still be a time when you can keep tabs on diabetes in a subtle way without needles, implants or other methods that might be painful, inconvenient or simply conspicuous.

23andMe says gene report can detect the risk of type 2 diabetes

-text c-gray-1" >23andMe is betting that its gene testing kits can help identify another major health risk: diabetes. The company plans to offer a report that identifies your genetic predisposition toward type 2 (that is, adult onset) diabetes. Unlike the company's earlier reports, the test provides a polygenic score based on gene variant research data from roughly 2.5 million customers, 70,000 of which reported diabetes — it's not relying on any public information. Ideally, this would help you change your diet and habits to reduce the chance of developing diabetes.

The company is partnering with Lark Health to offer the company's $20 per month AI health coaching service to customers who are at risk of developing diabetes. The report will be available to gene testing kit buyers starting March 11th, 23andMe said.

Whether or not it helps is another story. Experts talking to MIT Technology Review noted that polygenic scoring methods aren't extremely accurate at this stage, even though they've improved considerably since 23andMe dropped many of its health tests in 2013. While the company says its diabetes test is accurate for black, Asian and Latino customers, polygenic score predictions have historically produced worse results for non-Europeans.

There's also the nature of diabetes itself. There's no singular, guaranteed genetic signal that you're at risk, and those external factors like diet and lifestyle can make a large difference. If you already eat well and stay fit, the test won't change much. Still, this is a rare opportunity to gauge your susceptibility to diabetes at home. If nothing else, it could encourage you to visit the doctor.

глюкометр

Глюкометры

бесплатный глюкометр

глюкометр

глюкометр

глюкометр

Bionic pancreas and beyond: Here's how tech helps life with diabetes

id=«article-body» class=«row» section=«article-body»> One sunny day last July, I was chatting with my cousin Kathryn as we watched her daughter Ruby, now eight, dashing around the garden of my childhood home in Manchester, England, a cute red and white polka-dot bag slung over her shoulder.

It was an idyllic scene, one that stands in stark contrast to just six months earlier, бесплатный глюкометр when Ruby, who had exhibited few symptoms other than inordinate hunger and thirst, was rushed to hospital and diagnosed with type 1 diabetes. What followed was a six-day baptism of fire as Ruby was stabilized and forced to deal with her mortal dread of needles, while Kathryn and her husband underwent sleepless nights and a crash course in endocrinology.

«It was like having a new-born baby, but it's even harder, because you weren't expecting it,» she told me. Life suddenly became about monitoring, calculating, injecting, and planning around eating, exercise and school — all on no sleep and all totally out of the blue.

That cute bag that Ruby (name changed to protect her privacy) carries with her at all times? It houses a Dexcom glucose monitor and a pack of glucose tablets, which work in conjunction with the sensor attached to her arm and the insulin pump plugged into her stomach. The final item in her bag was an iPhone 5S.

The content's of Ruby's bag.

Kathryn Bond It's unusual for such a young child to have a smartphone. But Ruby's iPhone, which connects via Bluetooth to her Dexcom monitor, глюкометр allowing Kathryn to read it remotely, illustrates the way technology has transformed the management of diabetes from an entirely manual process — pricking fingers to measure blood sugar, writing down numbers in a notebook, calculating insulin doses and injecting it — to a semi-automatic one. It removes a lot of the guesswork involved with the timing and calculation of insulin doses by providing detailed, almost real-time monitoring of blood sugar levels.

Diabetes is not a small problem. Nearly 10 percent of the US population — just over 30 million people in total — are affected by the disease. Of those, 1.25 million Americans have type 1 diabetes, Глюкометры which puts them at risk of slipping into a fatal coma at any time and for which there's no cure. Instead, patients must treat and manage the disease, in which the body produces little or no insulin to regulate blood sugar levels, Глюкометры as best they can every day for the rest of their lives.

For all people with type 1 diabetes — often diagnosed in childhood — and for some with type 2, this means injecting themselves with insulin on a regular basis.

It was Ruby's case that inspired me to look into diabetes and how technology has made treatment less of a pain. Blood sugar levels can now be read almost in real time by devices such as continuous glucose monitors and бесплатный глюкометр insulin supplied via a pump continuously fixed to the body.

A diabetes pump means no injections, but does mean carrying the tech round your waist at all times.

Kathryn Bond But tech is not a complete panacea.

To start with, the most advanced tech isn't always available to everyone, бесплатный глюкометр and millions around the world don't have access to even basic gear like blood-glucose testing machines, according to Elizabeth Rowley, founder of charity T1International. It's led to some people «hacking» their equipment to take advantage of new capabilities.

It also adds new layers of complication to an already complicated disease.

«Technology is great as it gives us lots more information, but it doesn't take diabetes away and it doesn't take the management of diabetes away,» said Libby Dowling, who is senior clinical adviser at Diabetes UK and who has 11 years of experience as a children's diabetes nurse.

Pumps, which negate the need for injections, can also fail as the areas they're attached to gradually become insulin-resistant, meaning they have to be changed, which takes time. Having reams of data accessible might give an accurate snapshot of what's going on in the body, but it also increases the number of decisions you need to make. Real-time availability of the data can lead some parents to compulsively check on their child's blood sugar, in the same way many people do with social media.

«Parents find it really reassuring knowing that they can check in on what their child is up to and what their levels are and all that kind of thing,» said Dowling. «But it can also increase anxiety.»

When Ruby was diagnosed, Kathryn was warned by doctors not to be a perfectionist about monitoring and decision making. «The more tech you have, the more complicated it gets,» she said. «We have chargers coming out of our ears.»

And yet, she tells me: «The good hugely outweighs the bad for us — by a huge margin.»

#WeAreNotWaiting
Even in Australia, where Kathryn's family is based, the wait for new tech to actually become available is frustrating for well-informed parents who want and can afford the best possible care for their children.

One example Kathryn gave me is the lack of ability to connect an Apple Watch's cellular capability to the Dexcom G5 glucose monitor (it can only be used with Bluetooth via an iPhone.) Ruby's older sister, Lucy (name also changed), was diagnosed with type 1 diabetes eight months later, and uses the Dexcom G5, too. Being able to monitor the girls from her wrist is high on Kathryn's wish list of improvements she'd like to see in diabetes tech.

There are people who are unwilling to wait, and who embrace unorthodox methods. (You can find them on Twitter via the hashtag #WeAreNotWaiting.)

The Nightscout Foundation, an online diabetes community, figured out a workaround for the Pebble Watch. Groups such as Nightscout, Tidepool and OpenAPS are developing open-source fixes for diabetes that give major medical tech companies a run for their money.

Mission: Bionic Pancreas
One major gripe of many tech-enabled diabetes patients is that the two devices they wear at all times — the monitor and the pump — don't talk to each other. For many years, the community has been waiting for a «closed-loop» system, often referred to as an artificial pancreas, through which the insulin pump could respond automatically and in real time to the monitor's readings.

For as long as pumps and sensors fail and need changing at the drop of a hat, diabetes will never be a hands-off disease to manage, but an artificial pancreas is basically as close as it gets. The FDA approved the first artificial pancreas — the Medtronic 670G — in October 2017. But thanks to a little DIY spirit, people have had them for years.

Take Dana Lewis, founder of the open-source artificial pancreas system, or OpenAPS. Lewis started hacking her glucose monitor to increase the volume of the alarm so that it would wake her in the night.

From there, Lewis tinkered with her equipment until she created a closed-loop system, which she's refined over time in terms of both hardware (she uses a Raspberry Pi) and algorithms that enable faster distribution of insulin. It has massively reduced the «cognitive burden» on her everyday life, she told me over email. She no longer has to constantly think about diabetes before, during and after everything she does.

Hacking a glucose monitor is not without risk — inaccurate readings, failed alarms or the wrong dose of insulin distributed by the pump could have fatal consequences — but as with much of the highly inexact science around diabetes management, some people believe it's worth the tradeoff. Lewis and the OpenAPS community encourage people to embrace the build-your-own-pancreas method rather than waiting for the tech to become available and affordable.

They aren't alone. JDRF, one of the biggest global diabetes research charities, said in October that it was backing the open-source community by launching an initiative to encourage rival manufacturers like Dexcom and Medtronic to open their protocols and make their devices interoperable.

«This would allow seamless, secure connectivity between devices — much as your cell phone and personal electronics are able to connect wirelessly,» the charity explains in a blog post.

CNET Daily News
Get today's top news and бесплатный глюкометр reviews collected for you.
Just like every tech option for diabetes, choosing to use a closed-loop system is a decision heavily dependent on personal preferences. «An automated insulin delivery system is a different way of dealing with diabetes,» Lewis said. «You have to learn to build trust, and learn what to do differently, and how to use the tools to best help you achieve your goals.»

Kathryn told me it's not something she'd be willing to experiment with for her daughters, but she understands why people do it. «If it were me [with diabetes], I'd be straight on that,» she said.

Although experts like JDRF Research Director Daniel Finan believe the DIY route is safe, those methods won't have gone through rigorous tests performed by regulators, which means they remain in the Wild West territory of tech for now. Gradually this is changing. Along with Medtronic, US-based startups such as Bigfoot Biomedical and Beta Bionics are attempting to bring officially regulated artificial pancreases to market.

Lewis is encouraged by JDRF's initiative and can see a day commercial devices will catch up to what the DIY community is doing, but it's a question of time.

«I think it's likely going to be the second or third generation of these devices that get to where we DIYers are today, and especially around the needed interoperability and flexibility to really allow an individual to have this technology fit their particular lifestyle,» she said.

Baby steps to better lives
In the meantime, even incremental updates to existing tech have the potential to make massive differences in the lives of people with diabetes. Dexcom last month introduced its latest device, the G6, which is the first continuous glucose monitor that doesn't require calibration via a fingerstick, a needled device used to take diabetes measurements.

The update to the girls' G5 monitors won't require fingerstick calibration.

Kathryn Bond That's a huge deal because you have to prick your finger with the  fingerstick to get the measurements — multiple times a day. Continuous glucose monitors have reduced the use of fingersticks, but until the G6, monitors still required calibration, sometimes up to twice a day.

«When it comes to the treatment of diabetes, the most dreaded thing is the fingerstick,» said Dexcom CEO Kevin Sayers in an interview. «They just flat out hurt.»

Dexcom is the first company to successfully make sensors that don't need this constant recalibration.

«Think about if you're the parent of a child,» he said. «You've got to wake up in the middle of the night and stick your child's finger two or three times.» The consequences aren't just that it is uncomfortable for the child, but leaves both the parent and child exhausted.

All diabetes, all tech trade-offs, all the time
Sleeplessness is something Kathryn and her husband experienced a lot in the early stages of Ruby's diabetes diagnosis.

Using Dexcom's monitors with an alarm that goes off if glucose levels go haywire has helped remedy this. It's one of a list of reasons she favors it over other monitors, even though the girls have a Medtronic pump, which means she has to have two apps on her phone (and on theirs) and two sets of data to analyze.

A year into life with diabetes, Kathryn can tell me the pros and cons of practically every monitor out there, as well as their compatibility with pumps and infusion sets (the girls each prefer different ones) or injections. Whatever combination of tech you choose, she said, «it's always a trade-off.»

The girls prefer different pumps, which they also like to wear slightly differently.

Kathryn Bond Finding the right combination of the tech for each of the girls has been a trial-and-error process that will continue to evolve as the girls grow older, face new life challenges and develop different preferences about how much technology they're willing to be constantly hooked up to.

Through Facebook groups she belongs to, Kathryn has heard about the different ways this can play out from parents of other children with type 1 diabetes who've trodden the path before her. A type 1 diagnosis in the family is a shock to the system in many ways, but the help of online communities can prevent it from being quite so isolating. They're a source of tech support, but also of «huge kindness,» Kathryn told me.

So far, Lucy and Ruby have coped «fantastically well,» but as they grow up, they'll also have to start to take more responsibility for managing the disease for themselves. It will relieve some of the work Kathryn has to do — she knows parents who've given up work following a diagnosis, it's so labor-intensive. But for the girls the burden of monitoring and controlling the tech as well as physically carrying it everywhere they go will not be a light one to shoulder.

«You are constantly thinking diabetes, because it impacts every single thing you do,» said Kathryn. «It's the constancy of it, and it never goes away.»

Tech Enabled: CNET chronicles tech's role in providing new kinds of accessibility.

It's Complicated: This is dating in the age of apps. Having fun yet?

If you can't have the P30 Pro, have these instead: This top phone has some worthy alternatives.

iOS 13 could bring the health tools you need: Apple's update for iPhone is about more than dark mode.

Share your voice
Comments Tags
Tech Enabled Phones Sci-Tech

Fitbit's latest acquisition could help you manage health conditions

-text c-gray-1" >Fitbit is very familiar with the health care world, and its latest acquisition drives that point home. The company has bought Twine Health, whose centerpiece is a health coaching platform that helps you manage chronic conditions (such as diabetes and hypertension) and complete " Глюкометры глюкометр глюкометр Глюкометры Глюкометры бесплатный Глюкометры глюкометр lifestyle interventions" like weight loss or quitting smoking. The move will help Fitbit offer its wares to health plans and self-insured companies — and, to no one's surprise, gives it a chance to make more money from subscriptions.

The deal should wrap before the end of March.

While Fitbit isn't more specific about what it would like to do, it's not hard to see where the company is going. Its Ionic smartwatch can already talk to glucose monitors, and heart rate tracking has been a staple of its activity trackers for years. Health care and insurance providers could offer Fitbit devices to help you meet your goals without as many doctor's appointments or sky-high insurance premiums.

Stem cell breakthrough could help cure type 1 diabetes

-text c-gray-1" >Scientists have edged one step closer to a major treatment for (and possibly cure for) type 1 diabetes. A UCSF team has claimed it's the first to turn human stem cells into the mature, insulin-producing cells that type 1 patients don't have. The key was to acknowledge a reality in the development of islets, or clusters of healthy beta cells (which generate insulin) in the pancreas. They separated partly differentiated pancreatic stem cells into islets, jumpstarting their development and leading to responses to blood sugar that more closely represented mature cells. Even alpha and delta cells grew more effectively, UCSF said.

The technique has only been tested in mice so far, but the results were positive. It took just a " бесплатный глюкометр Глюкометры Глюкометры matter Глюкометры бесплатный глюкометр Глюкометры бесплатный глюкометрwww.shfc666.com — of days" for implanted islets to produce insulin as well as the rodents' native cells.

If the research continues to bear fruit, though, it could offer a much more realistic solution for type 1 diabetes. Pancreas transplants can help, but they frequently fail and still require drugs that suppress your immune system. There are tests for safer and more targeted islet implants, but they still tend to require organs from dead donors. This breakthrough could lead to on-demand implants and make it relatively easy to gain (or regain) healthy insulin levels.

Researchers develop a painless glucose monitor for diabetics

-text c-gray-1" >For those with diabetes, monitoring blood glucose is an essential part of disease management, but unfortunately, the methods for tracking glucose each have their own downsides. Finger-pricking can be a hassle and quite painful, while continuous glucose monitoring systems (CGMS) are often expensive, invasive and less reliable. But researchers at the KTH Royal Institute of Technology in Sweden have developed a microneedle-based CGMS that's more accurate, faster and cost-effective than what's currently available and is also pain-free.

The device they created is a patch outfitted with tiny microneedles that are thinner than a human hair and 50-times smaller than those on commercially available products. Because of this, when the patch is applied, it's practically painless and far less invasive than available CGMS products. Further, the smaller needles mean measurements can be taken within the dermis, where glucose measures are more accurate, as opposed to the hypodermis, which is where available CGMS devices typically target. The researchers' design also minimizes the distance between the sensing electrode and the dermis, allowing for more rapid readings, and utilizes a passive extraction of fluid, negating the need for more involved extraction processes that can contribute to higher costs.

While the device isn't yet available for use, the research team is working on completing the system in order to advance it to a clinical trial. Their work was recently published in Biomedical Microdevices.

глюкометр

глюкометр

бесплатный глюкометр

Глюкометры (www.asa-alger.org)

глюкометр

глюкометр

FDA approves AI-powered software to detect diabetic retinopathy

-text c-gray-1" >30.3 million Americans have diabetes according to a 2015 CDC study. An additional 84.1 million have prediabetes, which often leads to the full disease within five years. It's important to detect diabetes early to avoid health complications like heart disease, stroke, amputation of extremities and vision loss. Technology increasingly plays an important role in early detection, too. In that vein, the US Food and Drug Administration (FDA) has just approved an AI-powered device that can be used by non-specialists to detect diabetic retinopathy in adults with diabetes.

Diabetic retinopathy occurs when the high levels of blood sugar in the bloodstream cause damage to your retina's blood vessels. It's the most common cause of vision loss, according to the FDA. The approval comes for a device called IDx-DR, a software program that uses an AI algorithm to analyze images of the eye that can be taken in a regular doctor's office with a special camera, the Topcon NW400.

The photos are then uploaded to a server that runs IDx-DR, which can then tell the doctor if there is a more than mild level of diabetic retinopathy present. If not, it will advise a re-screen in 12 months. The device and software can be used by health care providers who don't normally provide eye care services. The FDA warns that you shouldn't be screened with the device if you have had laser treatment, eye surgery or injections, as well as those with other conditions, like persistent vision loss, blurred vision, floaters, previously diagnosed macular edema and more.

Глюкометры

бесплатный глюкометр

глюкометр

Глюкометры

Глюкометры

Глюкометры